Abstract
Cardiac imaging with positron emission tomography offers unrivaled sensitivity and specificity to probe cardiovascular physiology in health and disease. The use of positron emission tomography to noninvasively measure regional myocardial blood flow and assess myocardial viability in patients with ventricular dysfunction and coronary artery disease has contributed greatly to our understanding of the pathophysiology of ischemic heart failure. The advances and the need for further studies to establish both the natural history of such ventricular dysfunction and the role of coronary revascularization are discussed.
| Original language | English |
|---|---|
| Pages (from-to) | 399-418 |
| Number of pages | 20 |
| Journal | Progress in Cardiovascular Diseases |
| Volume | 43 |
| Issue number | 5 |
| DOIs | |
| Publication status | Published - 2001 |
Fingerprint
ASJC Scopus subject areas
- Cardiology and Cardiovascular Medicine
Cite this
The contribution of positron emission tomography to the study of ischemic heart failure. / Dutka, David P.; Camici, Paolo G.
In: Progress in Cardiovascular Diseases, Vol. 43, No. 5, 2001, p. 399-418.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - The contribution of positron emission tomography to the study of ischemic heart failure
AU - Dutka, David P.
AU - Camici, Paolo G.
PY - 2001
Y1 - 2001
N2 - Cardiac imaging with positron emission tomography offers unrivaled sensitivity and specificity to probe cardiovascular physiology in health and disease. The use of positron emission tomography to noninvasively measure regional myocardial blood flow and assess myocardial viability in patients with ventricular dysfunction and coronary artery disease has contributed greatly to our understanding of the pathophysiology of ischemic heart failure. The advances and the need for further studies to establish both the natural history of such ventricular dysfunction and the role of coronary revascularization are discussed.
AB - Cardiac imaging with positron emission tomography offers unrivaled sensitivity and specificity to probe cardiovascular physiology in health and disease. The use of positron emission tomography to noninvasively measure regional myocardial blood flow and assess myocardial viability in patients with ventricular dysfunction and coronary artery disease has contributed greatly to our understanding of the pathophysiology of ischemic heart failure. The advances and the need for further studies to establish both the natural history of such ventricular dysfunction and the role of coronary revascularization are discussed.
UR - http://www.scopus.com/inward/record.url?scp=0035103389&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0035103389&partnerID=8YFLogxK
U2 - 10.1053/pcad.2001.20673
DO - 10.1053/pcad.2001.20673
M3 - Article
C2 - 11251127
AN - SCOPUS:0035103389
VL - 43
SP - 399
EP - 418
JO - Progress in Cardiovascular Diseases
JF - Progress in Cardiovascular Diseases
SN - 0033-0620
IS - 5
ER -